Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Recovery includes managing pain, following post-operative care instructions, and undergoing rehabilitation for speech and swallowing if needed. Follow-up visits are crucial for monitoring progress.

A positive result suggests recent infection with Leptospira bacteria, indicating acute leptospirosis.

Yes, the test detects IgM antibodies present in the early phase of infection, helping to diagnose acute leptospirosis.

No, IgM antibodies decline over time. Additional tests may be needed to confirm chronic infection.

No specific precautions are necessary. Follow any instructions provided by your healthcare provider based on your results.

Consult a healthcare provider for further evaluation, as additional tests or clinical assessment may be necessary.